34 studies found for:    " November 19, 2008":" December 19, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
2 Active, not recruiting Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
3 Completed Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
Conditions: HIV-1;   HIV Infections
Intervention: Drug: Raltegravir
4 Completed Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia
Conditions: HIV;   Contraception;   HIV Infections
Interventions: Drug: Depo Provera;   Device: Copper T Intrauterine contraception device
5 Completed
Has Results
Lopinavir/Ritonavir (Kaletra) PK in Children
Conditions: HIV/AIDS Treatment;   HIV Infections
Intervention: Drug: lopinavir/ritonavir (Kaletra®) tablets
6 Active, not recruiting Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector
Condition: HIV Infections
Interventions: Biological: DNA Vaccine;   Biological: DNA Vaccine placebo;   Biological: rAd35;   Biological: rAd35 placebo;   Biological: rAd5;   Biological: rAd5 placebo
7 Unknown  Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
Conditions: Dry Eye Syndromes;   HIV Seropositivity
Interventions: Drug: cyclosporine and sodium carboximethycellulose;   Drug: sodium carboximethycellulose
8 Unknown  Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Maraviroc;   Drug: Tenofovir/Emtricitabine
9 Active, not recruiting A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents
Condition: Human Immuno Deficiency (HIV) Infections
Interventions: Drug: TMC278;   Drug: Zidovudine;   Drug: Abacavir;   Drug: Tenofovir disoproxil fumarate;   Drug: Lamivudine;   Drug: Emtricitabine
10 Completed Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Conditions: Cardiovascular Risk;   HIV Infection
Interventions: Dietary Supplement: Lovaza;   Dietary Supplement: sugar pill
11 Completed Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy
Conditions: Pregnancy;   Malaria;   HIV Infections
Interventions: Drug: Sulphadoxine-pyrimethamine;   Drug: Mefloquine (full dose);   Drug: Mefloquine (split dose);   Drug: placebo;   Drug: mefloquine
12 Unknown  Examination of B Cell Responses in Human Blood
Condition: HIV Infections
Intervention:
13 Completed Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
Conditions: Nasal Colonization With Staphylococcus Aureus;   HIV Infections
Interventions: Drug: Mupirocin calcium ointment, 2%;   Drug: Placebo ointment
14 Unknown  Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Conditions: HIV Infection;   Hemophilia A
Intervention:
15 Active, not recruiting Micronutrients and Antioxidants in HIV Infection
Condition: HIV Infection
Interventions: Dietary Supplement: Micronutrients and antioxidants;   Dietary Supplement: Multivitamins and minerals
16 Completed Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort
Condition: HIV Infections
Interventions: Drug: Zoledronic acid;   Behavioral: Lifestyle modifications
17 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Intervention: Drug: Anti-HIV Agents
18 Completed A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Conditions: Human Immunodeficiency Virus;   Human Papillomavirus- 6, 11, 16, 18;   Adolescent;   Papillomavirus Vaccines
Interventions: Drug: GARDASIL (Quadrivalent HPV (Types 6,11, 16, 18);   Biological: Administration of 3 doses of quaddrivalent;   Behavioral: Administration of an on line web-based risk
19 Completed A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States
Condition: HIV-1 Infections
Interventions: Drug: dapivirine;   Drug: placebo
20 Recruiting Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Efavirenz (EFV);   Drug: Rifampin-containing anti-TB therapy

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years